DexCom Q1 Beats Estimates

DexCom’ (DXCM) adjusted net loss narrowed to $0.32 per share in Q1 from $0.49 loss per share a year earlier, a smaller loss than analysts’ estimates of $0.36 loss per share in a Capital IQ poll.

Revenue grew 30% versus the same quarter of the prior year to $184.4 million, exceeding the $172.66 million estimate.

For 2018. the company now expects revenue of $850 million to $860 million, up from the prior range of $830 million to $850 million. The Street view is for revenue of $843.8 million.

Leave a Reply

Your email address will not be published. Required fields are marked *